HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Okamoto, F. Articles by Bugyi, H. Search for Related Content PubMed PubMed Citation Articles by Okamoto, F. Articles by Bugyi, H.

The Journal of Thoracic and Cardiovascular Surgery, Vol 92, 573-582, Copyright © 1986 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association

ARTICLES

Reperfusate composition: supplemental role of intravenous and intracoronary coenzyme Q10 in avoiding reperfusion damage

F Okamoto, BS Allen, GD Buckberg, J Leaf and H Bugyi

This study tests the hypothesis that the oxygen radical scavenger coenzyme Q10 can be given both intravenously and in the cardioplegic solution and can improve muscle salvage following surgical revascularization. Pilot studies were carried out in dogs undergoing 40 minutes of coronary artery ligation with reperfusion with normal blood, with the heart in the beating, working state. Intravenous infusions of coenzyme Q10 (10 mg/kg) 5 minutes before reperfusion resulted in improved recovery of creatine phosphate, adenosine triphosphate, total adenine nucleotide, and myocardial function reverse estimated by postextrasystolic potentiation, in comparison with the degree of recovery in untreated dogs. Experimental studies were done on 27 dogs undergoing 2 hours of left anterior descending coronary artery occlusion and subsequent reperfusion with and without total vented bypass. Thirteen dogs received intravenous coenzyme Q10 10 minutes before extracorporeal circulation, six received substrate-enriched blood cardioplegic solution with added coenzyme Q10, and six received normal blood reperfusate. Six others had cardioplegic reperfusion without coenzyme Q10. The systolic bulging that occurred during ischemia (ultrasonic crystals) persisted after reperfusion with normal blood (-25% systolic shortening, p less than 0.05), and 44% transmural triphenyltetrazolium chloride nonstaining occurred in the area at risk. Conversely, hearts receiving substrate-enriched blood cardioplegic solution recovered 37% contractility (p less than 0.05), with the least, and only, subendocardial triphenyltetrazolium chloride nonstaining (25% of area at risk) occurring with intravenous coenzyme Q10 before bypass and coenzyme Q10 supplementation of the cardioplegic solution. Intravenous coenzyme Q10, given just before reperfusion (possibly in transit to the operating room), enhances the role of substrate-enriched blood cardioplegic solution (especially when added to the cardioplegic solution) in salvaging ischemic myocardium and allowing immediate functional recovery.

This article has been cited by other articles:

				I. George and M. C. Oz Myocardial Revascularization after Acute Myocardial Infarction Card. Surg. Adult, January 1, 2008; 3(2008): 669 - 696. [Full Text]

				D. C. Lee, W. Ting, and M. C. Oz Myocardial Revascularization after Acute Myocardial Infarction Card. Surg. Adult, January 1, 2003; 2(2003): 639 - 658. [Full Text]

				D. P. Taggart, M. Jenkins, J. Hooper, L. Hadjinikolas, M. Kemp, D. Hue, and G. Bennett Effects of Short-Term Supplementation With Coenzyme Q10 on Myocardial Protection During Cardiac Operations Ann. Thorac. Surg., March 1, 1996; 61(3): 829 - 833. [Abstract] [Full Text]

				F. Beyersdorf Protection of Evolving Myocardial Infarction and Failed PTCA Ann. Thorac. Surg., September 1, 1995; 60(3): 833 - 838. [Abstract] [Full Text]

				R. Zhen, D. Wenxiang, S. Zhaokang, G. Xinling, H. Huiming, L. Jingfeng, Y. Qing, Z. Weizhong, and Y. Xiaoqing Mechanisms of brain injury with deep hypothermic circulatory arrest and protective effects of coenzyme Q10 J. Thorac. Cardiovasc. Surg., July 1, 1994; 108(1): 126 - 133. [Abstract] [Full Text]

				Y.-F. Chen, Y.-T. Lin, and S.-C. Wu Effectiveness of coenzyme Q10 on myocardial preservation during hypothermic cardioplegic arrest J. Thorac. Cardiovasc. Surg., January 1, 1994; 107(1): 242 - 247. [Abstract] [Full Text]